newsfilter
← Latest News
Business Wire·

Veracyte Secures Medicare Coverage for TrueMRD Monitoring Test in Muscle-Invasive Bladder Cancer

Marks the first Medicare coverage decision for Veracyte's whole-genome sequencing-based TrueMRD platform and launch of the first test Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced